טוען...
Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era
Recent reports suggest that in the TKI era, the survival of chronic myeloid leukemia approaches that of general population. The real-world situation may be different. We analyzed patients (≥ 18 years) with chronic phase (CP) CML enrolled over a 7-year period (2002–2008) in an imatinib access program...
שמור ב:
| הוצא לאור ב: | Indian J Hematol Blood Transfus |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer India
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6369098/ https://ncbi.nlm.nih.gov/pubmed/30828146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-018-1009-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|